Removing Barriers to Allergy Diagnostic Testing Act of 2019
USA116th CongressHR-2009| House
| Updated: 4/2/2019
Yvette D. Clarke
Democratic Representative
New York
Cosponsors (19)
Mark Meadows (Republican)Marc A. Veasey (Democratic)Mark Pocan (Democratic)Lisa Blunt Rochester (Democratic)Eliot L. Engel (Democratic)Bobby L. Rush (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)Vicente Gonzalez (Democratic)Fred Upton (Republican)Joseph D. Morelle (Democratic)G. K. Butterfield (Democratic)Raja Krishnamoorthi (Democratic)James A. Himes (Democratic)Jamie Raskin (Democratic)Diana DeGette (Democratic)Seth Moulton (Democratic)Suzanne Bonamici (Democratic)Bill Johnson (Republican)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Removing Barriers to Allergy Diagnostic Testing Act of 2019 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
AllergiesHealth care costs and insuranceHealth care coverage and accessMedicaidMedical tests and diagnostic methodsMedicare
Removing Barriers to Allergy Diagnostic Testing Act of 2019
USA116th CongressHR-2009| House
| Updated: 4/2/2019
Removing Barriers to Allergy Diagnostic Testing Act of 2019 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Yvette D. Clarke
Democratic Representative
New York
Cosponsors (19)
Mark Meadows (Republican)Marc A. Veasey (Democratic)Mark Pocan (Democratic)Lisa Blunt Rochester (Democratic)Eliot L. Engel (Democratic)Bobby L. Rush (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)Vicente Gonzalez (Democratic)Fred Upton (Republican)Joseph D. Morelle (Democratic)G. K. Butterfield (Democratic)Raja Krishnamoorthi (Democratic)James A. Himes (Democratic)Jamie Raskin (Democratic)Diana DeGette (Democratic)Seth Moulton (Democratic)Suzanne Bonamici (Democratic)Bill Johnson (Republican)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
AllergiesHealth care costs and insuranceHealth care coverage and accessMedicaidMedical tests and diagnostic methodsMedicare